| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 | Mar'16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||||||||||
Net (loss) income | ||||||||||||||||
-1,307 | 4,283 | 2,431 | 2,785 | 1,472 | 2,355 | 1,746 | 2,572 | -50 | 2,230 | 1,342 | 3,787 | -1,504 | 2,379 | 492 | 988 | -980 |
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||||||||||||||||
Depreciation and amortization | ||||||||||||||||
730 | 955 | 750 | 769 | 1,064 | 1,263 | 787 | 1,224 | 463 | 727 | 409 | 366 | 298 | 124 | 238 | 226 | 211 |
Net amortization of premiums and discounts on securities available-for-sale | ||||||||||||||||
-43 | - | - | - | -68 | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred income taxes | ||||||||||||||||
979 | 177 | 1,521 | 712 | -2,264 | - | - | - | - | - | - | - | - | - | - | - | -801 |
Stock-based compensation expense | ||||||||||||||||
2,728 | 2,437 | 2,330 | 2,274 | 2,783 | 2,336 | 2,380 | 1,777 | 1,481 | 1,131 | 967 | 1,180 | 957 | 1,030 | 709 | 75 | 75 |
Change in allowance for doubtful accounts | ||||||||||||||||
- | - | - | - | - | - | - | - | - | - | 260 | 34 | -330 | - | - | - | - |
Changes in assets and liabilities: | ||||||||||||||||
Accounts receivable | ||||||||||||||||
-2,663 | 5,763 | 2,923 | 3,097 | -2,671 | 4,153 | 2,650 | 3,320 | -3,414 | 3,342 | 1,929 | 1,655 | -4,044 | 1,187 | 580 | 1,248 | -2,493 |
Net investment in leases | ||||||||||||||||
735 | 519 | 1,759 | 2,507 | 3,362 | - | - | - | - | - | - | - | - | - | - | - | - |
Inventories | ||||||||||||||||
3,304 | 2,177 | 3,717 | 1,844 | 132 | -3,009 | -1,518 | 1,781 | 3,616 | 665 | 744 | 2,698 | 379 | 306 | 303 | 717 | -553 |
Income taxes | ||||||||||||||||
4,153 | -4,479 | 593 | 428 | 1,030 | -2,255 | -1,151 | 1,289 | 1,952 | -2,643 | 110 | 3,885 | 1,378 | - | - | - | - |
Prepaid expenses and other assets | ||||||||||||||||
-192 | 748 | 433 | 6 | -21 | -218 | 1,589 | -168 | -63 | -16 | 224 | -157 | -197 | 906 | -679 | 246 | -66 |
Right of use operating lease assets | ||||||||||||||||
-151 | -518 | -119 | 3 | 9 | - | - | - | - | - | - | - | - | - | - | - | - |
Medicare accounts receivable, non-current | ||||||||||||||||
973 | 1,159 | 416 | 437 | 288 | 873 | -637 | -1,323 | 253 | -53 | -190 | 92 | 46 | 1,179 | -143 | -24 | -228 |
Accounts payable | ||||||||||||||||
4,741 | -2,368 | -658 | 915 | 722 | 1,198 | -817 | -576 | 885 | 375 | -764 | 1,384 | -533 | -288 | 759 | 1,267 | -331 |
Accrued payroll and related taxes | ||||||||||||||||
-1,804 | -1,238 | 4,330 | 169 | -584 | -871 | 2,772 | 664 | -1,850 | 826 | 2,762 | -1,768 | -1,806 | 2,442 | 2,263 | 166 | -1,534 |
Accrued expenses and other liabilities | ||||||||||||||||
1,044 | 656 | 588 | 208 | 277 | 924 | 559 | 7 | -756 | -104 | 897 | 505 | 183 | 1,211 | -842 | 1,043 | -588 |
Future product royalties | ||||||||||||||||
- | - | - | - | - | - | - | - | -2 | - | -8 | -14 | -19 | -198 | -230 | -248 | -248 |
Net cash provided by operating activities | ||||||||||||||||
909 | 89 | 1,570 | -422 | 1,273 | 5,323 | 5,083 | 774 | -2,173 | 4,159 | 3,048 | -2,699 | -316 | 2,697 | 3,665 | 1,527 | -856 |
Cash flows from investing activities | ||||||||||||||||
Proceeds from sales of securities available-for-sale | ||||||||||||||||
- | - | - | - | - | 0 | 1,000 | 0 | 1,000 | - | - | - | - | - | - | - | - |
Proceeds from maturities of securities available-for-sale | ||||||||||||||||
10,000 | 9,000 | 4,500 | 7,000 | 4,500 | 4,000 | 3,000 | 4,000 | 4,000 | - | - | - | - | - | - | - | - |
Proceeds from sales and maturities of marketable securities | ||||||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | 1,000 | - | - | - | - |
Purchases of marketable securities | ||||||||||||||||
- | - | - | - | - | - | - | - | - | - | 1,002 | 1,000 | 10,049 | - | - | - | - |
Purchases of property and equipment | ||||||||||||||||
358 | 1,170 | 2,516 | 1,029 | 731 | 1,812 | 684 | 1,268 | 432 | 1,793 | 437 | 816 | 700 | 257 | 206 | 200 | 112 |
Intangible assets costs | ||||||||||||||||
36 | 388 | 57 | 53 | 44 | - | - | - | - | 30 | 21 | 15 | 8 | - | - | - | - |
Net cash provided by investing activities | ||||||||||||||||
9,606 | 954 | -7,003 | -11 | 3,725 | -9,498 | 217 | -10,013 | 4,568 | -823 | -1,460 | -1,976 | -9,757 | -11,302 | -224 | -206 | -112 |
Cash flows from financing activities | ||||||||||||||||
Taxes paid for net share settlement of restricted stock units | ||||||||||||||||
1,160 | 284 | 89 | 608 | 2,410 | 457 | 131 | 603 | 1,188 | 109 | 125 | 139 | 14 | - | - | - | - |
Proceeds from exercise of common stock options | ||||||||||||||||
172 | 996 | 296 | 681 | 861 | 297 | 647 | 433 | 138 | 161 | 94 | 479 | 100 | 12 | 28 | 68 | 128 |
Fees paid for IPO | ||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 3,887 | 457 | 433 |
Net cash used in financing activities | ||||||||||||||||
-988 | 1,913 | 207 | 1,925 | -1,549 | 1,138 | 516 | 1,246 | -1,050 | 979 | -31 | 2,057 | 86 | 12 | 29,134 | -389 | -305 |
Net increase in cash and cash equivalents | ||||||||||||||||
9,527 | 2,956 | -5,226 | 1,492 | 3,449 | -3,037 | 5,816 | -7,993 | 1,345 | 4,315 | 1,557 | -2,618 | -9,987 | -8,593 | 32,575 | 932 | -1,273 |
Supplemental cash flow disclosure | ||||||||||||||||
Cash paid for taxes | ||||||||||||||||
311 | 18 | 4 | 141 | 181 | 2,435 | 12 | 152 | 284 | 0 | 25 | 893 | 5 | 897 | 297 | 13 | 951 |
Non-cash investing activities: | ||||||||||||||||
Capital expenditures incurred but not yet paid | ||||||||||||||||
155 | -679 | 665 | -40 | 176 | -17 | 97 | -9 | 96 | -82 | -197 | 56 | 238 | 137 | -44 | 28 | 53 |